Weight-Loss Drug Zepbound Is Being Tested as a Treatment for Long Covid
GLP-1s are being studied for a wide range of conditions. Now, scientists will test whether their anti-inflammatory properties can help alleviate symptoms of long Covid.
Visit SiteBlogswired.com
Myer's online sales soar 61% but net loss slumps to AU$172m due to COVID-19zdnet.com
Tech adapted to COVID-19. How will it adapt post-COVID-19?zdnet.com
COVID cybercrime: 10 disturbing statistics to keep you awake tonightzdnet.com
Covid-19 prompts sharp decline in Q2 cell phone sales in Brazilzdnet.com
NSW government's QR code check-in system for COVID-19 contact tracing goes livezdnet.com
OpenAI is rolling out a free version of its Advanced Voice mode.theverge.com
FTC: BurnLounge runs a pyramid scheme... selling digital music storesarstechnica.com
Microsoft out of race to purchase TikTok as US ban draws nearzdnet.com
We can’t try Alexa Plus ourselves in the demo area.theverge.com
Slack is kinda down.theverge.com
Turning space missions into board gameszdnet.com
Contact tracing: England's app finally gets a launch datezdnet.com
Paramount Plus keeps piling on new subscribers.theverge.com
UK city taps thin clients and mainframes for greener computingarstechnica.com
Chuwi AeroBook Plus review: An affordable 15-inch laptop with a 4K displayzdnet.com
Apple pie in the sky? Long due products we want to see next weekzdnet.com
COVID-19: How CCPA enforcement impacts coronavirus screeningzdnet.com
Powerbeats Pro 2 review: the workout buds to beattheverge.com